CW

Claude Wildmann

LR Ludwig Institute For Cancer Research: 5 patents #106 of 611Top 20%
📍 Brussels, BE: #257 of 1,743 inventorsTop 15%
Overall (All Time): #1,038,652 of 4,157,543Top 25%
5
Patents All Time

Issued Patents All Time

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
6680056 METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORMALITY SOME OF WHOSE ABNORMAL CELLS PRESENT COMPLEXES OF HLA-CW 1601/MAGE-1 DERIVED PEPTIDES, AND METHODS FOR TREATING SAID INDIVIDUALS Pierre van der Bruggen, Jean-Pierre Szikora, Pierre Coulie, Pascale Boel, Thierry Boon-Falleur 2004-01-20
6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens Pascale Bo{haeck over (e)}l, Thierry Boon-Falleur, Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld 2003-10-28
6465184 Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecules HLA-Cw*1601 and uses thereof Pascale Bo{haeck over (e)}l, Thierry Boon-Falleur, Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld 2002-10-15
6110694 Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules Pascale Boel, Thierry Boon-Falleur, Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld 2000-08-29
5877017 Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof Pascale Boel, Thierry Boon-Falleur, Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld 1999-03-02